{
    "Trade/Device Name(s)": [
        "B\u00dcHLMANN fCAL turbo",
        "CALEX Cap",
        "B\u00dcHLMANN fCAL turbo Reagent Kit",
        "B\u00dcHLMANN fCAL turbo Calibrator Kit",
        "B\u00dcHLMANN fCAL turbo Control Kit"
    ],
    "Submitter Information": "B\u00dcHLMANN Laboratories AG",
    "510(k) Number": "K191718",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190784"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NXO"
    ],
    "Summary Letter Date": "September 24, 2019",
    "Summary Letter Received Date": "June 26, 2019",
    "Submission Date": "June 26, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.5180"
    ],
    "Regulation Name(s)": [
        "Fecal calprotectin immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Calprotectin (MRP8/14)"
    ],
    "Specimen Type(s)": [
        "Stool"
    ],
    "Specimen Container(s)": [
        "CALEX Cap",
        "Single use tube with extraction buffer"
    ],
    "Instrument(s)/Platform(s)": [
        "Clinical chemistry analyzers",
        "Roche cobas c501/c502"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-enhanced turbidimetric immunoassay (PETIA)",
        "Immunoparticle agglutination",
        "Automated absorbance measurement"
    ],
    "Methodologies": [
        "Turbidimetry",
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Extraction kit",
        "Calibrator",
        "Control",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for B\u00dcHLMANN fCAL turbo and CALEX Cap for quantitative measurement of fecal calprotectin using PETIA method on clinical chemistry analyzers",
    "Indications for Use Summary": "Aids in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn's disease and ulcerative colitis, and differentiation of IBD from irritable bowel syndrome (IBS) by measuring fecal calprotectin in stool, in conjunction with other laboratory and clinical findings",
    "fda_folder": "Immunology"
}